Genedant

RyboDyn is a biotechnology research company focused on developing innovative therapeutics aimed at training the immune system to identify and eliminate cancer from within the body. By leveraging cutting-edge scientific breakthroughs, RyboDyn creates advanced treatments that promise significant improvements in the management of terminal diseases and various ailments. The company's commitment to enhancing medicine through its research positions it at the forefront of the fight against cancer, with the potential to transform patient care and outcomes.

Auristone is a developer of an epigenetics platform that specializes in analyzing cancer patients, particularly focusing on Asian cancers. The company's innovative platform utilizes proprietary pipelines and predictive models to deliver actionable clinical insights and analyses based on epigenomic information. By providing demonstrable clinical evidence and meaningful correlations with other diseases, Auristone empowers clinicians to make informed treatment decisions for advanced cancers. This approach enhances personalized medicine, ultimately aiming to improve patient care through tailored therapeutic strategies.

Fable Food Co is a company that specializes in plant-based meat alternatives, primarily utilizing shiitake mushrooms to replicate the taste and texture of traditional meat. The organization focuses on creating minimally processed, clean label products made from all-natural ingredients, catering to the growing demand for healthier and sustainable food options. Fable's offerings are widely available in major Australian grocery chains such as Harris Farm Markets, Coles, and Woolworths, as well as through meal delivery services like Marley Spoon and Dinnerly. Additionally, its products can be found on various restaurant menus across Australia, Singapore, and the UK, making them accessible to a diverse range of consumers seeking vegan substitutes for meat dishes.

Umami Bioworks is a company focused on the discovery and development of a scalable platform for producing cultivated seafood, aiming to protect endangered marine species while providing consumers with sustainable seafood options. The company utilizes systems engineering to enhance the discovery and industrialization processes, facilitating local production that is both price competitive and environmentally responsible. Its innovative approach involves creating cell-based food products derived from fish cells and tissue, which are designed to be free from harmful substances such as mercury, antibiotics, microplastics, and ocean pollutants. By offering affordable, cell-cultured seafood and meat alternatives, Umami Bioworks addresses the growing demand for healthy and sustainable food choices.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.